In the August issue of Asia Pacific BioNet, an editorial by the COO, John Dangerfield, was published entitled “Stem Cell Therapies – what happened and where next?”. APBN is subscription-only but the article can be downloaded here APBN V17 No8_Feature_Stem Cell Therapies